Skip to main content
          Skip to FDA Search
          Skip to in this section menu
          Skip to footer links


U.S. flagAn official website of the United States government

					Here’s how you know
          			Dot gov**The .gov means it’s official.**Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
							      SSL**The site is secure.** The **https://** ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely. 
			U.S. Food and Drug Administration
				
        Search
            Menu
							
						Search FDA
									
									Submit search 
		Featured
							Contact FDA
	                FDA Guidance Documents
	                Recalls, Market Withdrawals and Safety Alerts
	                Press Announcements
	                Warning Letters
	                Advisory Committees
	                En Español

					Products
            Food
							Drugs
							Medical Devices
							Radiation-Emitting Products
							Vaccines, Blood, and Biologics
							Animal and Veterinary
							Cosmetics
							Tobacco ProductsTopics
            About FDA
							Combination Products
							Regulatory Information
							Safety
							Emergency Preparedness
							International Programs
							News and Events
							Training and Continuing Education
							Inspections and Compliance
							Science and ResearchInformation For
            Consumers
	            Patients
	            Industry
	            Health Professionals
	            Federal, State and Local Officials 
 In this section:

                Advancing Regulatory Science

Advancing Regulatory Science

                        Regulatory Science Extramural Research and Development Projects
          Advancing Regulatory Science News and Upcoming Events
          Centers of Excellence in Regulatory Science and Innovation (CERSIs)
          Past News and Events - Advancing Regulatory Science


                        Focus Areas of Regulatory Science Report Home
          Science & Research
          Science and Research Special Topics
          Advancing Regulatory Science
          Maximizing Benefits and Minimizing Harms from Antibiotics: Scientific, Regulatory and Clinical Considerations by Dr. Sara Cosgrove - 11/08/2022Advancing Regulatory Science Webcast
    Event Title
              Maximizing Benefits and Minimizing Harms from Antibiotics: Scientific, Regulatory and Clinical Considerations by Dr. Sara Cosgrove


                  November 8, 2022

  

    
  Share
    Post
    Linkedin

    Email
    PrintOn This Page
      Meeting InformationDate:
          
  


     
           

November 8, 2022   

 
 
        
                                      Time: 
                                      
3:00 PM
    - 4:00 PM
ET

 





Johns Hopkins University CERSI

**Tuesday, November 8th, 2022**

Presented By

Sara Cosgrove, MD
**Sara Cosgrove, MD**
Professor of Medicine in the Division of Infectious Disease
Associate Hospital Epidemiologist
Johns Hopkins University School of Medicine

About the Presentation

Antibiotics are one of the most important discoveries in modern medicine, saving countless lives and allowing for advances in management of non-infectious diseases. However, their use can be associated with harms such as organ toxicity, Clostridioides difficile infection, and emergence of resistance at the patient and population level. This presentation addressed approaches to optimize antibiotic use through antibiotic stewardship including updated regarding federal regulations, strategies to enhance antibiotic stewardship and minimize antibiotic-associated adverse events throughout all healthcare settings, and approached to change attitudes and behavior around antibiotic prescribing.

About the Presenter

Dr. Sara Cosgrove is a Professor of Medicine in the Division of Infectious Disease (ID) at Johns Hopkins University School of Medicine and has a joint appointment in the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health. She is the Director of Research for the ID Fellowship Program and PI of the T32 training grant that supports ID fellow training. She serves as the Director of the Department of Antimicrobial Stewardship and the Associate Hospital Epidemiologist at The Johns Hopkins Hospital. Dr. Cosgrove’s research interests include the epidemiology and outcomes of antimicrobial resistance, the development of tools and programs to promote the rational use of antimicrobials, the prevention of hospital-acquired infections and the epidemiology and management of S. aureus bacteremia. Early in her career, she recognized the critical need to study antimicrobial stewardship strategies and has led a series of outcomes studies over the past 15 years that have defined the practice of antimicrobial stewardship in the United States. Her recent research focuses on strategies for implementation of antimicrobial stewardship activities across all healthcare settings via a large, multi-center project including hospitals, long-term care facilities and ambulatory practices as well as assessing and quantifying harm associated with antibiotic therapy. She is a past Voting Member of the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria. She is a Past President of the Society for Healthcare Epidemiology’s Board of Directors. Dr. Cosgrove received her undergraduate degree from Columbia College, her medical degree from Baylor College of Medicine, and her Master of Science degree in epidemiology from Harvard School of Public Health. She completed her postgraduate training in internal medicine at The Johns Hopkins Hospital and underwent subsequent training in ID at Beth Israel Deaconess Medical Center.


Recording

**Link:** https://www.jhsph.edu/research/centers-and-institutes/center-of-excellence-in-regulatory-science-and-innovation/news-and-events/FDA-Sara-Cosgrove-Recording.html


For Questions:

Please contact LaToya Richardson at Latoya.Richardson@fda.hhs.gov.

                                                                                  Content current as of:
      12/16/2022More Meetings,
      Conferences, and
      Workshops
        
        Advancing Regulatory Science

          
                        Regulatory Science Extramural Research and Development Projects
          Advancing Regulatory Science News and Upcoming Events
          Centers of Excellence in Regulatory Science and Innovation (CERSIs)
          Past News and Events - Advancing Regulatory Science


                        Focus Areas of Regulatory Science Report
 
 Footer Links
    FDA Archive
          About FDA
          Accessibility
      Visitor Information
          Website Policies / Privacy
          No FEAR Act
          Vulnerability Disclosure Policy
      FOIA
          HHS.gov
          USA.gov
    Contact FDA
      Follow FDA on Facebook
      Follow FDA on X
      Follow FDA on Instagram
      Follow FDA on LinkedIn
      View FDA videos on YouTube
      Subscribe to FDA RSS feeds
    FDA Homepage
    Contact Number
      1-888-INFO-FDA (1-888-463-6332) Back toTop